Global Custom Market Research Reports Provider Company

phone

Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 31 Jul 2018
  • Number of Pages: 36
  • Category: SWOT Analysis
  • Country: United States of America
Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The companys flagship product, Aurix System, is a biodynamic hematogel designed to harness a patients innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has its facilities in Nashville, Tennessee; and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc Key Recent Developments

Jul 05,2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies
Apr 10,2017: Nuo Therapeutics appoints Dr. Paul D. Mintz to its board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData
Section 1 - About the Company 5
Nuo Therapeutics Inc - Key Facts 5
Nuo Therapeutics Inc - Key Employees 6
Nuo Therapeutics Inc - Key Employee Biographies 7
Nuo Therapeutics Inc - Major Products and Services 8
Nuo Therapeutics Inc - History 9
Nuo Therapeutics Inc - Company Statement 11
Nuo Therapeutics Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 13
Company Overview 13
Nuo Therapeutics Inc - Business Description 14
Nuo Therapeutics Inc - Corporate Strategy 15
Nuo Therapeutics Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Nuo Therapeutics Inc - Strengths 16
Nuo Therapeutics Inc - Weaknesses 17
Nuo Therapeutics Inc - Opportunities 18
Nuo Therapeutics Inc - Threats 19
Nuo Therapeutics Inc - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 Companys Lifesciences Financial Deals and Alliances 28
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Nuo Therapeutics Inc, Recent Deals Summary 30
Section 5 Companys Recent Developments 31
Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 31
Section 6 Appendix 32
Methodology 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables


Nuo Therapeutics Inc, Key Facts 5
Nuo Therapeutics Inc, Key Employees 6
Nuo Therapeutics Inc, Key Employee Biographies 7
Nuo Therapeutics Inc, Major Products and Services 8
Nuo Therapeutics Inc, History 9
Nuo Therapeutics Inc, Other Locations 12
Nuo Therapeutics Inc, Subsidiaries 12
Nuo Therapeutics Inc, Key Competitors 20
Nuo Therapeutics Inc, Ratios based on current share price 21
Nuo Therapeutics Inc, Annual Ratios 22
Nuo Therapeutics Inc, Annual Ratios (Cont...1) 23
Nuo Therapeutics Inc, Annual Ratios (Cont...2) 24
Nuo Therapeutics Inc, Interim Ratios 26
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Nuo Therapeutics Inc, Recent Deals Summary 30
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35

List Of Figures


Nuo Therapeutics Inc, Performance Chart (2013 - 2017) 25
Nuo Therapeutics Inc, Ratio Charts 27
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Glucose monitoring is key to tracking glucose metabolic disturbance, evaluating therapies and guiding further treatment. However, blood glucose levels vary with time. Finger sticks and selfmonitoring of blood glucose levels

View Report

Report Continuous Flow Installations-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Continuous Flow Installations industry, standing on the readers perspective, delivering detailed market data and

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports